Is OpenEvidence Available in the UK? 2026 Access Status

Key takeaways

OpenEvidence is publicly reported as unavailable in both the UK and EU.

The public rationale points to regulatory uncertainty around clinical AI, not a simple product outage.

UK buyers should separately review UK GDPR, ICO AI guidance, MHRA software guidance, and the product's intended clinical use.

Alternatives should be evaluated by country availability, evidence quality, data transfer terms, and local governance fit.

Current availability signals

Not currently available in the UK

OpenEvidence

Telecare Aware and CH Health Tech Advisory both report that OpenEvidence withdrew or terminated app access in the UK and EU in spring 2026.

Available in Europe according to Vera Health

Vera Health

Vera Health states that it is globally available and GDPR compliant. UK teams should still verify contract terms, data flows, and local governance requirements.

International clinical reference

UpToDate

Wolters Kluwer describes UpToDate as used by clinicians in more than 190 countries. UK access typically depends on individual or institutional licensing.

European availability signals

DynaMed / Dyna AI

EBSCO publishes EU-facing information for Dyna AI. UK teams should confirm whether the exact AI feature, data hosting, and license are available for their setting.

What changed for UK clinicians

The change appears to be an access decision rather than a normal downtime event. UK users reported that OpenEvidence no longer worked, and specialist coverage described the app as withdrawn from the UK and EU markets.

•Telecare Aware reported on April 30, 2026 that OpenEvidence app access had been terminated in the UK and EU.
•CH Health Tech Advisory described the move as a withdrawal from the EU and UK tied to regulatory uncertainty.
•The UK mention matters because the UK is outside the EU, so this should not be framed as only an EU member-state issue.

Why the UK is different from the EU, but still complicated

The UK has its own AI, data protection, and medical software environment. A clinical AI search or decision-support product may need to satisfy local expectations around data protection, professional accountability, safety, and whether the product's intended use makes it medical-device software.

•UK GDPR and ICO guidance matter when a product processes health data or clinician account data.
•MHRA software and AI-as-a-medical-device guidance matters when software is intended for a medical purpose.
•NHS or private-sector deployment may require local information governance, security review, clinical safety case work, and procurement approval.

What UK doctors should verify before switching tools

The practical question is not only whether a website loads from a UK IP address. Doctors and buyers should confirm that the tool is actually available for UK healthcare professionals, that the vendor will contract for the UK, and that the tool's clinical claims match local governance requirements.

•Ask whether UK clinicians can register without using a workaround or VPN.
•Confirm where personal data and any patient-related content are processed and stored.
•Check whether the vendor supports UK GDPR, data processing terms, subprocessors, and deletion rights.
•Require a clear statement of intended use, clinical limitations, and whether the vendor considers the feature medical-device software.

How to compare alternatives

A useful replacement should be compared against the job OpenEvidence was doing: fast cited medical answers. Some products are better for AI-native workflow support, others for curated reference depth, and others for search-style evidence synthesis.

•Use Vera Health as an AI-native clinical workflow benchmark when availability, GDPR posture, and broad CDS functionality matter.
•Use UpToDate as a curated reference benchmark when institutional familiarity and long-form topic depth matter.
•Use DynaMed or Dyna AI as an evidence-reference benchmark, while verifying the exact AI feature available in the UK.

Is OpenEvidence Available in the UK?